Constipation Treatment Market Set to Reach USD 17.69 Billion by 2031 as Treatment Demand Expands

The Global Constipation Treatment market is witnessing steady expansion as the prevalence of constipation increases across populations and demand grows for effective treatment options. According to The Insight Partners, constipation is a common condition experienced by 16% of the global population, with prevalence reaching 33.5% in 2023. Factors associated with the rising prevalence include improper diet, lack of physical activity, reduced bowel movement due to age progression, lifestyle factors, medication, and medical conditions. The increasing prevalence of constipation, together with product development and treatment launches, is supporting the expansion of the global Constipation Treatment market.

According to The Insight Partners, the Constipation Treatment Market size is projected to reach US$ 17.69 billion by 2031 from US$ 9.93 billion in 2022. The market is expected to register a CAGR of 6.0% during 2023–2031. The report highlights increasing demand for the treatment of opioid-induced constipation as a key market trend, while drug development, product launches, and approvals are expected to create further opportunities during the forecast period.

Download Sample PDF:
https://www.theinsightpartners.com/sample/TIPRE00005408

Constipation Treatment Market Size and Growth Outlook:

The Constipation Treatment market was valued at US$ 9.93 billion in 2023, while the annual market size is projected to reach US$ 17.69 billion by 2031. This growth represents a significant expansion of the market over the forecast period and reflects increasing demand for constipation treatment products and innovative therapeutic options. The market is anticipated to register a 6.0% CAGR from 2023 to 2031. The report also estimates the total addressable market during 2024–2031 at approximately US$ 104.18 billion. The increasing prevalence of constipation is one of the major factors driving market growth. Constipation can affect quality of life and cause psychological morbidity, increasing the need for effective treatment approaches. In addition, the growing geriatric population, changing dietary habits, and increasing prevalence of gastrointestinal disorders are expected to contribute to market development. Awareness campaigns by organizations and manufacturers, along with increasing research and development activities, are also expected to support the development of innovative treatment options.

Increasing Product Launches and Approvals Support Market Expansion

Increasing product launches, drug development activities, and regulatory approvals are important factors influencing the Constipation Treatment market. The report indicates that increasing FDA approvals and drug development activities are likely to accelerate market growth during the forecast period. Established and new market participants are developing constipation treatments, increasing product availability and supporting consumption. For example, in 2021, the US Food and Drug Administration approved the first generic drug linaclotide capsules in 145 microgram and 290 microgram strengths from Mylan Pharmaceuticals for irritable bowel syndrome with constipation and chronic idiopathic constipation. Such product approvals demonstrate the continued development of treatment options and contribute to the market’s growth outlook.

Buy Premium Report: https://www.theinsightpartners.com/buy/TIPRE00005408

Drug Development Creates New Market Opportunities:

Drug development represents an important opportunity for the Constipation Treatment market. Laxatives remain a conventional treatment for acute and mild constipation, while pharmaceutical developments have resulted in treatments such as lubiprostone, linaclotide, and prucalopride. At the same time, unmet needs remain among patients who do not respond adequately to existing therapies. The report identifies developments involving 5-HT4 receptor modulators, guanylate cyclase C agonists, and ileal bile acid transporter inhibitors as promising areas. In April 2022, Ardelyx launched IBSRELA, an NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation in adults. In August 2022, the FDA approved Vibrant, a therapy manufactured by Vibrant Gastro, for chronic constipation. Such developments are expected to provide growth opportunities for the market.

Constipation Treatment Market Segmentation:

The Constipation Treatment market is segmented by therapeutic, disease, distribution channel, and geography. Based on therapeutic, the market includes laxatives, chloride channel activators, peripherally acting mu-opioid receptor antagonists, GC-C agonists, and 5-HT4 receptor agonists. The laxatives segment held a larger market share in 2023. By disease, the market covers chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation. Chronic idiopathic constipation held the largest market share in 2023. By distribution channel, the market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies, with retail pharmacies dominating the market in 2023.

Regional Analysis of the Constipation Treatment Market:

The report covers North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. North America dominated the Constipation Treatment market, supported by the increasing prevalence of constipation and a growing geriatric population. Market participants developing constipation treatments are also expected to contribute to regional growth. Asia Pacific is anticipated to register the highest CAGR in the coming years.

Top Key Players in the Constipation Treatment Market:

The major companies profiled in the Constipation Treatment market include AbbVie Inc., Takeda Pharmaceutical Company Limited, Bausch Health Companies Inc., Bayer AG, Mallinckrodt Plc, Sanofi, Albireo Pharma Inc., AstraZeneca, Ironwood Pharmaceuticals Inc., Salix Pharmaceuticals Inc., Abbott Laboratories, Cosmo Pharmaceuticals NV, Valeant Pharmaceuticals International Inc., Pfizer Inc., and Synergy Pharmaceuticals Inc. The report evaluates industry participants and their competitive strategies and innovation developments.

Future Outlook for the Constipation Treatment Market:

The Constipation Treatment market is positioned for continued growth through 2031 as rising disease prevalence, increasing product launches, drug development, regulatory approvals, and research and development activities create opportunities across the industry. With the market projected to increase from US$ 9.93 billion in 2022 to US$ 17.69 billion by 2031, the 6.0% CAGR highlights a sustained growth trajectory for constipation treatment products and therapies.

Trending Reports:

Constipation Laxative Market Size, Share & Forecast by 2034
Constipation Nutraceuticals Market Share, Size & Demand by 2034

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.